Federal award (BPA CALL, fiscal year 2022)
Recipient: PROGENICS PHARMACEUTICALS INC
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2023-02-16 to 2023-09-30
Current total value of award: $631526
Description: RADIOACTIVE DRUG BPA ORDER INDICATED FOR POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITIVE LESIONS IN MEN WITH PROSTATE CANCER WITH SUSPECTED METASTASIS